DENTSPLY SIRONA Inc. (XRAY) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, XRAY scores 32 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are: Fundamental Cash Engine at 5/20 (ROIC of -11%, FCF yield of 12.27%); Whale 13F Flow at 8/20 (institutional accumulation and options positioning); Insider Conviction at 9/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 5/20 (Beta 1.0, sector sensitivity); and Forensic Balance Sheet at 5/20 (Altman Z 0.45, Piotroski F 6/9, Debt/Equity 1.5). The two weakest pillars, cash engine and balance sheet, sit on top of negative returns on capital and a low Altman Z, which together point to elevated financial-distress risk. The strongest pillar, insider and flow activity at 9/20, is still well below a constructive level. The high 12.27% FCF yield is the main valuation point in the bull case, but per the SEC financials it coexists with operating and net losses, so an investor would need to determine whether that cash generation is durable before weighting it heavily. Taken together, the rating frames XRAY as a name where forensic risk outweighs apparent cheapness.

Per the SEC financials, revenue declined from $3965.0M (FY 2023) to $3680.0M (FY 2025), and the company reported operating losses in each period shown. Per the market data, operating margin is -11.5%, net margin is -16.2%, and ROIC is -11%. The Altman Z-Score is 0.45 and the Piotroski F-Score is 6/9, both per the Roarable RQD rating. Debt rose from $1586.0M to $2015.0M over the FY 2024 to FY 2025 periods, and the Debt/Equity ratio is 1.5 per the Roarable RQD rating.

Per the news feed, recent headlines cover a Midwest dental expansion described as a "reset story," post-Q2 earnings buy/sell/hold commentary, a Simply Wall St piece framing the stock as possibly cheap with sales in focus, and a MarketBeat report of a new 52-week low. A Stock Titan item notes a webcast to review third-quarter results on Nov. 5. All news items carry a YELLOW light and MARKET WIRE impact label. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are present. Risk watch items per the news and financial sections include the 52-week low, continued operating losses, and rising debt.

• What are the drivers of the FY 2025 operating and net losses, and are they recurring or restructuring-related?
• What is the source of the FCF generation given the reported operating losses, and is it sustainable?
• How will the Q3 results referenced in the news feed affect the debt trajectory and Altman Z-Score?
• What is the company's earnings per share and valuation multiple profile, given that P/E, EPS, and EV/EBITDA are unavailable?
• Who holds the stock institutionally, and what are the 13F and insider transaction details?